EGEGamers.io
Cypherpunk’s $46M Zcash Markup Turns a $4.7M Operating Loss Into $39.4M of Net Income
Cypherpunk Technologies reported a net income of $39.4 million for the second quarter, largely due to a $46 million unrealized gain from its Zcash holdings. Excluding this accounting entry, the company incurred an operating loss of $4.7 million. The company's biotechnology subsidiary, Leap Therapeutics, is also seeking resources for its sirexatamab drug program.
